{"id":37679,"date":"2025-05-20T16:35:14","date_gmt":"2025-05-20T16:35:14","guid":{"rendered":"https:\/\/new.igihe.com\/french\/Rwanda-un-essai-vaccinal-innovant-ouvre-de-nouveaux-espoirs-dans-la-lutte-37679\/"},"modified":"2025-05-20T16:25:58","modified_gmt":"2025-05-20T16:25:58","slug":"Rwanda-un-essai-vaccinal-innovant-ouvre-de-nouveaux-espoirs-dans-la-lutte","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/french\/Rwanda-un-essai-vaccinal-innovant-ouvre-de-nouveaux-espoirs-dans-la-lutte\/","title":{"rendered":"Rwanda : un essai vaccinal innovant ouvre de nouveaux espoirs dans la lutte contre le VIH"},"content":{"rendered":"<p>La strat\u00e9gie vaccinale initiale consiste \u00e0 activer les cellules B, responsables de la production d\u2019anticorps essentiels \u00e0 une r\u00e9ponse immunitaire efficace. Les doses suivantes visent \u00e0 renforcer leur capacit\u00e9 \u00e0 d\u00e9tecter et neutraliser efficacement l\u2019intrusion du VIH.<\/p>\n<p>\u00ab Nous avons constat\u00e9 un renforcement significatif de la r\u00e9ponse immunitaire chez tous les participants, ce qui souligne le potentiel prometteur de cette approche \u00bb, a expliqu\u00e9 Rogier Sanders, professeur \u00e0 l\u2019Universit\u00e9 de M\u00e9decine d\u2019Amsterdam et membre de l\u2019\u00e9quipe scientifique supervisant l\u2019essai.<\/p>\n<p>Parall\u00e8lement, une autre voie de recherche s\u2019appuie sur la technologie de l\u2019ARN messager (ARNm), qui a d\u00e9j\u00e0 d\u00e9montr\u00e9 son efficacit\u00e9 dans la lutte contre la Covid-19, pour induire une immunit\u00e9 fond\u00e9e sur ces m\u00eames anticorps ciblant le virus. Cependant, certains participants \u00e0 cet essai ARNm ont pr\u00e9sent\u00e9 des effets secondaires cutan\u00e9s. <\/p>\n<p>Malgr\u00e9 ces effets secondaires, les chercheurs soulignent que la technologie ARNm permettrait d\u2019acc\u00e9l\u00e9rer consid\u00e9rablement la production des vaccins, constituant un avantage majeur dans la lutte contre le VIH.<\/p>\n<p>Selon l\u2019agence Reuters, ces essais cliniques ont \u00e9t\u00e9 conduits aux \u00c9tats-Unis, au Rwanda et en Afrique du Sud, des pays particuli\u00e8rement touch\u00e9s par l\u2019\u00e9pid\u00e9mie.<\/p>\n<p>D\u2019apr\u00e8s les donn\u00e9es de l\u2019Organisation mondiale de la sant\u00e9 (OMS), pr\u00e8s de 39,9 millions de personnes vivaient avec le VIH dans le monde en 2023, dont 65 % sur le continent africain.<\/p>\n<p>Ce vaccin, qui renforce le syst\u00e8me immunitaire en ciblant des cellules sp\u00e9cifiques, n\u2019avait jusqu\u2019alors jamais \u00e9t\u00e9 test\u00e9 en Afrique. Pourtant, les r\u00e9sultats d\u00e9montrent une efficacit\u00e9 notable tant chez les populations am\u00e9ricaines qu\u2019africaines, ouvrant ainsi de nouvelles perspectives prometteuses dans la pr\u00e9vention du VIH.<\/p>\n<figure class=\"spip-document spip-document-61146 aligncenter\"><img decoding=\"async\" src=\"https:\/\/fr.igihe.com\/IMG\/jpg\/hiv.jpg\" alt=\"Le Rwanda a pris part \u00e0 un essai vaccinal contre le VIH, r\u00e9cemment men\u00e9 par des chercheurs\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Le Rwanda a pris part \u00e0 un essai vaccinal innovant r\u00e9cemment men\u00e9 par des chercheurs, dont les r\u00e9sultats prometteurs reposent sur la stimulation de cellules immunitaires essentielles, renfor\u00e7ant ainsi la production d&#8217;anticorps charg\u00e9s de combattre le VIH, ouvrant un nouvel espoir dans la lutte contre cette maladie.<\/p>\n","protected":false},"author":488,"featured_media":4000061145,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7546],"tags":[7605],"byline":[7717],"hashtag":[],"class_list":["post-37679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sante-20","tag-homenews","byline-igihe"],"bylines":[{"id":7717,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":393}],"contributors":[{"id":7717,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":393}],"featured_image":{"id":4000061145,"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","alt":"","caption":"","mime_type":"image\/jpeg","width":0,"height":0,"sizes":{"thumbnail":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","width":1,"height":1},"medium":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","width":1,"height":1},"medium_large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","width":1,"height":1},"large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","width":1,"height":1},"full":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/hiv_cp.jpg","width":0,"height":0}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/37679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/users\/488"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/comments?post=37679"}],"version-history":[{"count":0,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/37679\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media\/4000061145"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media?parent=37679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/categories?post=37679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/tags?post=37679"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/byline?post=37679"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/hashtag?post=37679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}